Venturi Wealth Management LLC Sells 1,825 Shares of The Cooper Companies, Inc. $COO

Venturi Wealth Management LLC reduced its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 37.9% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,994 shares of the medical device company’s stock after selling 1,825 shares during the period. Venturi Wealth Management LLC’s holdings in Cooper Companies were worth $213,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. JPMorgan Chase & Co. boosted its holdings in Cooper Companies by 3.4% in the 1st quarter. JPMorgan Chase & Co. now owns 5,177,008 shares of the medical device company’s stock worth $436,681,000 after buying an additional 172,485 shares during the period. Goldman Sachs Group Inc. boosted its holdings in Cooper Companies by 17.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company’s stock worth $399,340,000 after buying an additional 686,751 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in Cooper Companies by 12.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,954,877 shares of the medical device company’s stock worth $333,595,000 after buying an additional 425,400 shares during the period. Millennium Management LLC boosted its holdings in Cooper Companies by 36.0% in the 1st quarter. Millennium Management LLC now owns 2,577,416 shares of the medical device company’s stock worth $217,405,000 after buying an additional 682,166 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Cooper Companies by 15.5% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,121,835 shares of the medical device company’s stock worth $178,977,000 after buying an additional 284,943 shares during the period. 24.39% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts recently commented on COO shares. Robert W. Baird cut their price objective on shares of Cooper Companies from $97.00 to $85.00 and set an “outperform” rating for the company in a report on Thursday, August 28th. Wells Fargo & Company cut their price objective on shares of Cooper Companies from $93.00 to $72.00 and set an “overweight” rating for the company in a report on Thursday, August 28th. Needham & Company LLC reiterated a “buy” rating and issued a $94.00 target price on shares of Cooper Companies in a research note on Thursday, August 28th. Wall Street Zen cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Saturday, July 12th. Finally, BNP Paribas upgraded shares of Cooper Companies from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $84.75.

Insider Activity

In other Cooper Companies news, COO Daniel G. Mcbride bought 3,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 2nd. The shares were bought at an average price of $65.04 per share, for a total transaction of $195,120.00. Following the transaction, the chief operating officer directly owned 63,120 shares in the company, valued at $4,105,324.80. This trade represents a 4.99% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Gerard H. Warner III bought 1,450 shares of the firm’s stock in a transaction that occurred on Friday, September 5th. The stock was acquired at an average price of $69.23 per share, for a total transaction of $100,383.50. Following the transaction, the chief operating officer owned 18,319 shares in the company, valued at $1,268,224.37. This trade represents a 8.60% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 17,975 shares of company stock worth $1,216,346. Corporate insiders own 1.98% of the company’s stock.

Cooper Companies Stock Performance

Cooper Companies stock opened at $68.37 on Friday. The firm’s fifty day moving average price is $69.43 and its 200-day moving average price is $73.66. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12. The stock has a market cap of $13.59 billion, a P/E ratio of 33.68, a price-to-earnings-growth ratio of 1.79 and a beta of 1.02. The Cooper Companies, Inc. has a fifty-two week low of $61.78 and a fifty-two week high of $109.37.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.07 by $0.03. The firm had revenue of $1.06 billion for the quarter, compared to analysts’ expectations of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The business’s quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter last year, the company posted $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies declared that its Board of Directors has approved a share repurchase program on Wednesday, September 17th that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the medical device company to reacquire up to 15.4% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s leadership believes its shares are undervalued.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.